Event

Connect with Quotient Sciences at the upcoming BIO International Convention 2023 in Boston, MA between June 5-8.

Schedule a meeting
Press enter to search

Suggested searches

Early Development
Candidate Selection
Late Development
ADME
Translational Pharmaceutics

Resources

Resource centre

Reset filters
12 / 180 resources
Scientific Posters
A Decade of Human ADME at Quotient Sciences: Reviewing Key Study Design Variables and Outcomes
A Decade of Human ADME at Quotient Sciences: Reviewing Key Study Design Variables and Outcomes.
Scientific Posters
Safety, tolerability, and pharmacokinetics of the oligomer modulator anle138b: a first-in-human randomised, double-blind, placebo-controlled Phase 1 trial
Safety, tolerability, and pharmacokinetics of the oligomer modulator anle138b: a first-in-human randomised, double-blind, placebo-controlled Phase 1 trial
Scientific Posters
ESMO Immuno-Oncology Poster - Hubro Therapeutics QSC204718 (Vaccine Study)
A Phase I Study of the Cancer-specific Vaccine FMPV-1 in Healthy Male Subjects to Assess Safety and Immune Response
Scientific Posters
Qualification of Gastroplus® PBPK modelling software to support decision-making in clinical development
Qualification of Gastroplus® PBPK modelling software to support decision-making in clinical development.
Peer Reviewed Publication
Controlled synthesis of SPION@SiO2 nanoparticles using design of experiments
Controlled synthesis of SPION@SiO2 nanoparticles using design of experiments.
Scientific Posters
ACoP 2022 Poster: Benznidazole pharmacokinetics in adults and children: Application of PBPK modelling
Benznidazole pharmacokinetics in adults and children: Application of PBPK modelling.
Scientific Posters
Development of a novel oral suspension formulation of a candidate API for administration to pediatric patients
Development of a novel oral suspension formulation of a candidate API for administration to pediatric patients.
Webinar
Streamlining the Delivery of 14C Human ADME Data: An ADME Q&A Roundtable
Experts from Quotient Sciences and The Netherlands Organization for Applied Scientific Research (TNO) discuss streamlining human ADME studies.
Scientific Posters
AAPS 2022 Poster: Kilo Scale Synthesis in Daisy Chained Flow Reactors
Quotient Sciences AAPS 2022 Poster, "Kilo Scale Synthesis in Daisy Chained Flow Reactors." (2R, 6R) hydroxynorketamine is a pharmaceutical undergoing trials as an antidepressant. An atom efficient synthesis route with norketamine as an intermediate is known. A low throughput flow synthesis route to norketamine had previously been developed, 2 however a manufacturing scale method was required. The objective of this study is to conduct the entire synthesis of norketamine from 2 chlorophenylcyclopentyl ketone in daisy chained reactors, built mainly from readily available parts at a throughput of > 1 kg/day.
Scientific Posters
AAPS 2022 Poster: Formulation and Taste Assessments in First in Human Studies
Quotient Sciences AAPS 2022 Poster, "Formulation and Taste Assessments in First in Human Studies" is available to download here.
Info Sheet
Quotient Sciences Aseptic Development & Manufacturing Capabilities Info Sheet
Quotient Sciences has expertise in developing, manufacturing, testing, releasing, and supplying a range of formulations (IV, SC, and IM administration) for a variety of clinical study types, including first-in-human (FIH) healthy volunteer studies assessing safety, tolerability, and pharmacokinetics (PK), as well as radiolabeled formulations for human absorption, distribution, metabolism, and excretion (ADME) studies.
Info Sheet
Quotient Sciences' Collaboration with Charles River
Integrated programs that bridge molecules from early discovery to proof of concept (POC) and beyond.